États-Unis · Bourse & Finance · Reuters Business

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion

Publié par Reuters Business · États-Unis il y a 11 h

Hong Kong-listed Metis TechBio ‌on Monday said it has entered ⁠a collaboration agreement with Eli Lilly worth up to $1.1 billion for ‌the ⁠research and development of…

Lire l'article complet sur Reuters Business Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.reuters.com)

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion

À lire aussi

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC

HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion

Partager

À lire aussi

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

Made an ‘honest’ mistake with crypto taxes? New bill offers way out

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC